|
HY-51424-50mg
|
MedChemexpress LLC
|
PLX-4720 [CAS 918505-84-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-51424-1mL
|
MedChemexpress LLC
|
PLX-4720 [CAS 918505-84-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-13297-10mg
|
MedChemexpress LLC
|
PYZD-4409 [CAS 423148-78-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13297-100mg
|
MedChemexpress LLC
|
PYZD-4409 [CAS 423148-78-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13297-5mg
|
MedChemexpress LLC
|
PYZD-4409 [CAS 423148-78-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13297-50mg
|
MedChemexpress LLC
|
PYZD-4409 [CAS 423148-78-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13297-1mL
|
MedChemexpress LLC
|
PYZD-4409 [CAS 423148-78-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-N1417-10g
|
MedChemexpress LLC
|
Sesamol [CAS 533-31-3]
|
|
Cancer-programmed cell death
|
|
|
HY-N1417-25g
|
MedChemexpress LLC
|
Sesamol [CAS 533-31-3]
|
|
Cancer-programmed cell death
|
|
|
HY-115510-10mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-100mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-5mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-50mg
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-115510-1mL
|
MedChemexpress LLC
|
SPR inhibitor 3 [CAS 1292285-54-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-13002-10mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-100mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-200mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-5mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-50mg
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-13002-1mL
|
MedChemexpress LLC
|
Torin 2 [CAS 1223001-51-1] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-119402-10mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-100mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-25mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-5mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
|
HY-119402-50mg
|
MedChemexpress LLC
|
TP-021 [CAS 2130878-25-8]
|
|
Cancer-programmed cell death
|
|
